
About Raydiant Oximetry
Raydiant Oximetry is a Consumer company based in San Ramon (United States) founded in 2015 by Neil Ray. Wearable device for non-invasive fetal blood oxygen monitoring is offered. It operates on a HealthTech model in Consumer, Healthcare, and Technology sectors. Raydiant Oximetry has raised $25.7 million across 14 funding rounds from investors including March of Dimes, HHS and VCI Global. Its chief executive, as recorded, is Neil Ray. Raydiant Oximetry offers products and services including Lumerahâ„¢. Its focus areas include Medical Devices and Fetal Monitoring. Its legal entity is Raydiant Oximetry, Inc. Its competitors include kegg, Femometer and Noninvasix; 2 of its 3 listed competitors have raised funding.
Company details
Raydiant Oximetry, Inc. is focused on advancing fetal health monitoring during childbirth. The company is developing Lumerah, a noninvasive fetal pulse oximeter designed to measure fetal oxygen levels accurately. This technology aims to reduce maternal and neonatal mortality and morbidity by providing healthcare professionals with reliable data for decision-making during labor and delivery. Operating in the healthcare sector, specifically in medical devices, solutions are targeted at improving outcomes in obstetrics. Partnerships with organizations like GE HealthCare further support the enhancement of fetal monitoring capabilities.
- Headquarters San Ramon, United States
- Founders Neil Ray
- SectorsConsumerHealthcare Technology
- Email••••••••
- Phone•••• ••••
- Website raydiantoximetry.com
- Social LinkedIn X
- Legal Name Raydiant Oximetry, Inc.
- Total Equity Funding$25.7M (USD)
in 14 rounds
- Latest Funding Round$7.5M (USD), Series A
May 2024
- InvestorsMarch of Dimes
& 17 more
Products & Services of Raydiant Oximetry
Raydiant Oximetry offers a comprehensive portfolio of products and services, including Lumerah™.
Noninvasive fetal pulse oximeter for oxygenation monitoring.
Funding Insights of Raydiant Oximetry
Raydiant Oximetry has successfully raised a total of $25.7M across 14 strategic funding rounds. The most recent funding activity was a Series A round of $7.5 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.7M
- Total Rounds 14
- Last Round Series A — $7.5M
- First Round $1.94M
(Jul 2018)
- Investors Count 18
Latest 10 of 14 funding rounds of Raydiant Oximetry with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $7.5M | Series A | – | Cross Border Impact Ventures | |
| Feb 2023 | Series A | – | March of Dimes | – | |
| Jul 2021 | $5M | Series A | – | Avestria Ventures | |
| Aug 2020 | $999,392 | Grant | – | – | |
| Jul 2020 | $203,353 | Grant | – | – | |
| Feb 2020 | $50,000 | Series A | – | – | – |
| Dec 2019 | $900,000 | Series A | – | – | – |
| Oct 2019 | $5.6M | Series A | – | VCapital | |
| Sep 2019 | $3.17M | Series A | – | – | – |
| May 2019 | $2.48M | Seed | – | – | – |
18 investors in total: 18 institutional.
Investors in Raydiant Oximetry
Raydiant Oximetry has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include March of Dimes, HHS and VCI Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are focused on health technology for global impact. | crossborder.ventures | Toronto, Canada | ||
Venture capital investment opportunities are provided for accredited investors. | vcapital.com | |||
Avestria Ventures is focused on funding women's health and life science ventures. | avestria.vc | San Francisco, United States | ||
Angel investing in high-tech and life science startups since 1994. | bandangels.com | |||
Investments are focused on reproductive healthcare startups by Rhia Ventures. | rhiaventures.org | San Francisco, United States | ||
Investments are focused on innovations in women's health. | 2019 | femhealthventures.com | ||
Investments in healthcare startups are managed by SteelSky Ventures. | steelskyventures.com | Atlanta, United States | ||
VC funds investing in technology startups | trivalleyventures.com | Pleasanton, United States | ||
Kofa Healthcare is engaged in funding healthcare and biotech innovations. | kofahealthcare.com | |||
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States |
Investor details for Raydiant Oximetry
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Raydiant Oximetry
26 people are tracked at Raydiant Oximetry (12 in leadership, 10 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Neil Ray | Founder & CEO | Leadership |
Annie Theriault | Director | Leadership |
Debra Snowdale | CFO | Leadership |
Eric Johansson | VP Of R&d | Leadership |
Laura Kemp | Vice President Clinical Affairs | Leadership |
Russ DeLonzor | President And Chief Operating Officer | Leadership |
Robert Skidmore | Vice President Of Manufacturing | Leadership |
Paul Stetson | Chief Scientific Officer | Leadership |
Mark Rosen | Chief Medical Officer | Leadership |
Elizabeth Bailey | Director | Leadership |
Denise Malvehy | Vp, Global Marketing | Leadership |
Maureen A. Brennan | Director Of Clinical Research And Professional Education For Radiant Oximetry | Leadership |
Charles McDonald | Director | Board & advisors |
Jana Kainerstorfer | Advisor | Board & advisors |
Tom Garite | Advisor | Board & advisors |
Nate DeNicola | Advisor | Board & advisors |
Denise Zarins | Advisor | Board & advisors |
Declan O'Mahoney | Advisor | Board & advisors |
David Boas | Advisor | Board & advisors |
Edward Evantash | Advisor | Board & advisors |
6 more people are available in the full profile.
Complete people profiles for Raydiant Oximetry
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Raydiant Oximetry
3 dated milestones of Raydiant Oximetry across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Raydiant Oximetry is founded.
- Funding First funding round of $1.9M.
- Funding Latest funding round, Series A, of $7.5M.
Competitors of Raydiant Oximetry
Raydiant Oximetry has 3 listed competitors in our database, 2 of them funded. They include kegg, Femometer and Noninvasix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kegg.tech | 2017 | San Francisco, United States | $9.5M | 3 | Fertility tracking and pelvic health solutions are provided by kegg. | |
| femometer.com | 2015 | San Francisco, United States | Basal body temperature is tracked by Femometer for cycle monitoring. | |||
| noninvasix.com | 2007 | Galveston, United States | $5.95M | Developer of a fetal blood oxygenation monitoring device |
Detailed competitors of Raydiant Oximetry
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Raydiant Oximetry
The website of Raydiant Oximetry (raydiantoximetry.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 30.1% vs previous month
Websites whose visitors overlap most with Raydiant Oximetry. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
startuptrivalley.org | startuptrivalley.org | 100% | #8,625,407 | – | |
| vcapital.com | 93% | #6,797,256 | View details |
Top companies in Beauty & Personal Care Products
3 companies that operate in the same segment as Raydiant Oximetry (Beauty & Personal Care Products) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
3M is recognized as a global leader in industrial innovation. | 1902 | United States | USD 24.95 B | 74 | ||
Provider of FMCG conglomerate products | 1837 | United States | USD 457.23 M | 923 | ||
Subscription-based men's grooming products are provided by Harry's. | 2012 | New York, New York, United States | USD 755.88 M | 431 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Raydiant Oximetry
Complete news archive for Raydiant Oximetry
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raydiant Oximetry
Raydiant Oximetry was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Raydiant Oximetry is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Neil Ray is the CEO of Raydiant Oximetry, as recorded in our data. They have also founded this company.
Raydiant Oximetry is a funded company, having raised a total of $25.7M across 14 funding rounds to date. The company's 1st funding round was a Seed of $2.48M, raised on Jul 2018.
Raydiant Oximetry, Inc. is focused on advancing fetal health monitoring during childbirth. The company is developing Lumerah, a noninvasive fetal pulse oximeter designed to measure fetal oxygen levels accurately. This technology aims to reduce maternal and neonatal mortality and morbidity by providing healthcare professionals with reliable data for decision-making during labor and delivery. Operating in the healthcare sector, specifically in medical devices, solutions are targeted at improving outcomes in obstetrics. Partnerships with organizations like GE HealthCare further support the enhancement of fetal monitoring capabilities.
Raydiant Oximetry's top competitors include kegg, Femometer and Noninvasix.
Raydiant Oximetry offers Lumerahâ„¢.
Raydiant Oximetry has 18 investors. Key investors include March of Dimes, HHS, VCI Global, AngelMD, and Global Health Impact Network.
Raydiant Oximetry operates through Raydiant Oximetry, Inc..
